Distractify on MSNOpinion
Psychedelic researcher questions industry's rush to market
Johns Hopkins trial veteran warns venture capital threatens therapeutic integrity as psilocybin nears FDA approval ...
Stage 4 metastatic breast cancer presents significant emotional and psychological challenges, requiring patients to adapt ...
Opinion
A trans woman's cancer symptoms were almost missed — until gender affirming care saved her life
But when Trefzger went under the knife for facial feminization surgery, she had a stroke that caused blindness in her left eye. This was a tragic outcome, but the scans done in the wake of her stroke ...
This study came out of a multi-institutional collaboration called the BRCA BCY group, which is an international group of ...
Investor's Business Daily on MSN
Why Immunome, a top 3% stock, just rocketed on its rivalry with Merck KGaA
Top-notch biotech stock Immunome rocketed Monday after the company's treatment for desmoid tumors appeared to top an approved ...
Nurse practitioners discuss evidence-based cancer screening and risk-reduction strategies that primary care clinicians can implement for patients with HIV.
RWJUH and Rutgers Cancer Institute introduce Ion robotic bronchoscopy, enabling earlier, more precise lung cancer detection.
John Cena met a young cancer survivor before his final WWE match at Saturday Night’s Main Event. The meeting reinforced ...
Recurrent or metastatic nasopharyngeal carcinoma is an aggressive disease, and long-term survival with chemotherapy alone is ...
In this video, Erika Hamilton, MD, discusses HER2CLIMB-05 trial results demonstrating that the addition of tucatinib to maintenance therapy delayed metastatic breast cancer progression for ...
Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval making it the first ...
Although our study is still preliminary, it lays an important foundation for future research into the potential applications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results